A1AA Logo
“Our mission is to improve the health and well being of those affected by Alpha-1 through support to patients,
educating healthcare professionals and advancing public policy for the Alpha-1 Community.”

Won’t you sign up for membership? Simply click HERE


Home
A1AA Donation Shoppe
Mission Statement
What is Alpha-1
Need Help Now !
Informational Resources
  • Support
  • Medicine Support
  • Personal Advocacy
  • Education
  • Public Policy
    • Alpha-1 Vets
    Health Tips
    FAQs
    Caregivers
    Membership
    Management Team
    Press Room
    Feedback and Comment
    Our Partners and Links
    Alpha-1 Advocacy Summary

    Our Partner's
    in the Alpha
    Community



    Testing for AAT Deficiency
    Simply click HERE
    Alpha One International Registry
    provides AAT Deficiency Testing. This AAT Deficiency Testing is a
    COMPLETE ALPHA-1 TESTING SERVICE
    and WITHOUT COST TO YOU.
    Please read the detail at: AAT Deficiency Detection Center
    Welcome! to the Alpha-1 Advocacy Alliance!


    Ask Pat
    The Alpha-1 Advocacy Alliance is proud to announce the
    “Free Group Therapy Monthly Presentations”

    Wednesday: Jan 7, 2009 -- 7:00 pm Eastern time.

     Come listen and participate in a discussion

    “ASK PAT” -- Pat Slavin, LCSW and a veteran Alpha-1 patient herself, will host this free group therapy monthly presentation every first Wednesday of the month. She’s the expert so take this opportunity to get the answers! NEW Conference Call TELEPHONE NUMBER. Simply call the toll free number 1-888-246-1819 and punch in the code 0397510254 to listen in on the call. Pat’s presentation includes time to ask questions.

    June presentation      Transplant Part V "Fundraising"
    other presentations at      Support

    Ann Marie Benzinger, of Alpha-1 Advocacy Alliance spoke with Patrick Collins, Director of Public Affairs at CSL Behring, addressing the concerns of the alpha-1 patient community about the pending purchase of Talecris. The companies will file for regulatory approval with the appropriate authorities and, until approved, the companies will continue to operate as usual.

    Full details of conversation and announcement letter



    "Educational Scholarship Grant " The Alpha-1 Advocacy Alliance announce the availability of a new dedicated scholarship in honor of our Alphas lost. Many of our fellow Alphas have asked that donations be made to the A1AA in their honor at their passing. This bequest is now further recognized by going directly into the Alpha Memorial Educational Award. The Alpha-1 Advocacy Alliance will offer at least one $500.00 grant each year for secondary educations (college or graduate studies) to an Alpha-1 individual who fulfills the requirements of the grant.
    “Senate Passes Historic Bill on Genetic Information Nondiscrimination”
    Americans Can Take Advantage of Health Advances without Fearing Discrimination. The Genetic Information Nondiscrimination Act (GINA) paves the way for the responsible use of genetic information while protecting against discrimination with respect to health insurance and employment.
    “Kamada was Granted New Orphan Drug Designation...for the Treatment of Bronchiectasis”
    Kamada (TASE: KMDA), a biopharmaceutical company which develops, manufactures and markets specialty life-saving therapeutics, announces today that the company was granted an Orphan Drug Designation to its Aerosolized Alpha-1 Antitrypsin (AAT) product to treat Bronchiectasis.
    Finding an Article using     OJOSE. Online JOurnal Search Engine (OJOSE) is a free powerful scientific search engine enabling you to make search-queries in different databases by using only one search field.
    State-of-the-Art Fibroscan Technology ... For Liver Disease Diagnosis ... A new FibroScan® machine that uses the latest technology for diagnosing liver damage ... News Room
    FDA Approves Dey, L.P.’s Perforomist(TM) (Formoterol Fumarate). Inhalation Solution for long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD).
    Support Alpha-1 Advocacy Alliance
    It’s simple! It’s easy! Online shopping is fun and now, it can help Alpha-1 Advocacy Alliance. Simply sign up at www.igive.com and list A1AA as your target charity. Each time you purchase from a participating store, that store will donate up to 10% logo in your name to the Alpha-1 Advocacy Alliance. And, now ,when you sign up, they are offering an extra $5.00 donation. So, sign up today and help us help our fellow Alphas through the work of the Alpha-1 Advocacy Alliance.
    Panniculitis...Alpha1 Antitrypsin Deficiency ... Nodular panniculitis refers to inflammatory nodules in the subcutaneous fat. Nodules may be, single or multiple, localized or generalized, and vary in size from a few millimeters to several centimeters in diameter. They are generally firm, red and tender... full story
    Bone mass continues to increase in liver transplant patients, despite early loss. -- A new study on bone loss in patients with liver disease before and after transplant .
    Less drug better for transplant survival Immune system can accept donor tissue
    The regimen avoids steroids and encourages the immune system to welcome the donor tissue, explained Dr. Rakesh Sindhi, co-director of pediatric transplantation at Children’s Hospital.
    A1AA Shoppe is now open online! Check out the A1AA T-Shirts, iGive.com, Alphapotamus, renew and order new magazine subscriptions on line. Help raise money for the Alpha-1 Advocacy Alliance. Support the Alpha-1 Advocacy Alliance. Help us help our fellow Alphas through the work of the Alpha-1 Advocacy Alliance!
    Personal Oxygen Concentrator (POC)...Travel Usage
    Under the “Americans with Disabilities Act”, you may request a gate pass from the airline at the check-in counter for a friend to accompany you to/from the arrival/departure gate to retrieve/deliver your portable oxygen.
    Special Problems in Long-term Survivors of Lung Transplantation
    Many of the problems affecting long-term survivors are not well defined in terms of incidence or prevalence because many patients relocate and receive their “late” care in their hometowns.


    ...Alpha-1 Advocacy Alliance
    “News Room”


    ...Up to Date News...

    new “President Bush Signs Landmark Genetic Nondiscrimination Information Act Into Law”
    “Senate Passes Historic Bill on Genetic Information Nondiscrimination”
    “Kamada was Granted New Orphan Drug Designation...for the Treatment of Bronchiectasis”
    “China's drug watchdog...State inquiry into bogus blood scam.”
    “EMEA Approves Kamada’s Plans for Phase II/III Clinical Trials of the Aerosolized Form of AAT.”
    “China’s Drug Watchdog…State Inquiry into Bogus Blood Scam.”
    “State-of-the-Art Fibroscan Technology for Liver Disease Diagnosis.”
    “PARI And Kamada Announce Positive Intermediate Phase I Results for Inhaled Alpha-1 Antitrypsin.”
    “FDA Approves Dey, L.P.’s Perforomist(TM) (Formoterol Fumarate).”
    “Common Cold Virus Leads to Death in Lung-transplant Patients.”
    “A Statement from the NIH Director, Elias A. Zerhouni, M.D., Regarding the National Institutes of Health Reform Act of 2006.”
    “Talecris Continues Global Expansion into Europe.”
    “Three Things COPD Sufferers Should Know during the Cold Season.”
    “Gene Therapy Shows Promise against Hereditary Lung Disease.”



    The Phone Card Program to assist Alpha-1 Patients ( Personal Advocacy: “The Phone Card Program” ) The Alpha-1 Advocacy Alliance and Coram Healthcare are pleased to announce “Call Home on Us.” This new Personal Advocacy Program provides phone support for those needing a little bit of help when they are away from home. For complete details click on the link above.
    FOR INFO CALL: 540-948-6777 or
    Toll Free 1-866-FOR-A1AA    (1-866-367-2122)
    Fax # 540-948-6763
    Search our web site!
    Insert your “key words,” then click the “Google Search” button.
    Google
    WWW ALPHA1ADVOCACY.ORG
    Alpha-1 Advocacy Alliance
    PO Box 202, 103 Rapidan Church Lane Wolftown, VA 22748
    Copyright © 2006 Alpha-1 Advocacy Alliance, All Rights Reserved
    Home | Disclaimer | Privacy Policy | webmaster@alpha1advocacy.org